Skip to main content
News Icon

News categories: Publication

Hair loss gene discovery

Hairlessness, skin changes, a strong hypersensitivity to light: these are the symptoms of the so-called IFAP syndrome. Scientists from the universities of Beijing, Hamburg and Bonn have now identified a genetic defect that triggers the rare disorder. The results have been published in the "American Journal of Human Genetics". IFAP syndrome is very rare; Probably not even 100 people in Germany suffer from this congenital disorder. Those affected are sparsely hairy to complete hairlessness, even eyebrows and eyelashes may be missing. The skin is often keratinized; Sunlight or strong artificial light hurts the eyes. The abbreviation "IFAP" stands for the medical names of these three key symptoms.

In the medium term, the study could also open up new ways of treating IFAP syndrome. Perhaps, for example, the lack of cholesterol in the skin can be improved by special fatty ointments. However, further studies have to show whether this really works. The results already provide an insight into the diverse processes that must work together for the healthy development of skin and hair.


Publication

Huijun Wang u.a.: Mutations in SREBF1, Encoding Sterol Regulatory Element Binding Transcription Factor 1, Cause Autosomal Dominant IFAP Syndrome; American Journal of Human Genetics; DOI: https://doi.org/10.1016/j.ajhg.2020.05.006

Associated cluster scientists: Regina Betz

Related news

News Icon

News categories: Publication

Malaria Causes Permanent Damage to Phagocytes in the Spleen

Macrophages formed in the bone marrow can only assume the function of embryonal phagocytes, or “scavenger cells,” to a certain degree according to a study by the University of Bonn and the Peter Doherty Institute for Infection and Immunity at the University of Melbourne. The researchers have demonstrated that malaria infection causes permanent damage to resident CD163 macrophages in the spleen, which are responsible for cleaning the blood, recycling iron and communicating with other cells involved in the body’s immune response.
View entry
Tracking glioblastoma cell spread in human brain tissue

News categories: Publication

Core2Edge: How tumor cells conquer the brain

Glioblastoma is an aggressive brain tumor that infiltrates deep into the surrounding brain tissue. Even after surgery, tumor cells remain in the brain and the tumor recurs. Bonn researchers have now developed Core2Edge, a model based entirely on human tissue that captures these hard-to-access infiltration zones at the tumor margin. The model enables investigation of the invasive front and direct assessment of new drug candidates in human tissue - without the need for animal testing. The study of the Brain Tumor Translational Research Group has now been published in Nature Protocols.
View entry
Mikrochip zur Wiederherstellung zentralen Sehvermögens bei fortgeschrittener Makuladegeneration.

News categories: Publication

Approval of a Novel Retinal Implant Technology

A novel retinal implant is offering people with geographic atrophy the opportunity to regain part of their central vision for the first time. Geographic atrophy is a severe late stage of age-related macular degeneration. An international research team led by Prof. Frank G. Holz of the UKB and the University of Bonn demonstrated in an international clinical trial that the majority of participants experienced significant improvements in visual acuity. The novel retinal implant technology has now received approval for routine clinical use in Europe, making it available beyond clinical trials.
View entry

Back to the news overview